Domov › Lupusová nefritída › New York
Klinické štúdie Lupusová nefritída v štáte New York
16 štúdií pre Lupusová nefritída hľadá účastníkov v zariadeniach v štáte New York.
Mestá v štáte New York
Oficiálny text štúdie (anglicky)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Stony Brook Internists PC, East Setauket
Prebieha náborFáza 2
Vek 18 až 100 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05268289Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
- Circuit Clinical, Orchard Park
Prebieha náborFáza 3
Vek 18 až 100 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06711887A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- New York Medical College, Hawthorne
- NorthWell, New Hyde Park
Prebieha náborFáza 2
Vek 16 až 70 · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07328581VIBRANT: VIB4920 for Active Lupus Nephritis
- Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases, Manhasset
- Hospital for Special Surgery, New York: Division of Rheumatology, New York
- Columbia University Medical Center: Department of Medicine, Division of Rheumatology, New York
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT05201469The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Hospital for Special Surgery, New York
- Children's Hospital at Montefiore, New York
Prebieha náborFáza 2
Vek 8 až 20 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05538208A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, New York
- Research Site, Syracuse
Prebieha náborFáza 1/2
Vek 18 až 70 · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
Prebieha náborFáza 1
Vek 18 až 74 · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT07085104A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Cohen Children's Medical Center of New York, Queens
Prebieha náborFáza 2
Vek 5 až 17 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT05039619RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Rochester, Rochester
Prebieha náborFáza 1/2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Icahn School of Medicine at Mount Sinai, New York
- State University of New York Upstate Medical Center (SUNY), Syracuse
Prebieha náborFáza 2
Vek 12 až 65 · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT07053800PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Buffalo Rheumatology and Medicine, PLLC, Orchard Park
Prebieha náborFáza 4
Vek 18 až 75 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT07611214A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, New York
- Nkarta Investigational Site, Stony Brook
- Nkarta Investigational Site, Syracuse
Prebieha náborFáza 1/2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 4. 6. 2026 · NCT06557265A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
Prebieha náborFáza 1
Vek 12 až 70 · Všetky pohlavia · Aktualizované 22. 5. 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- The Feinstein Institutes for Medical Research, Manhasset
- Columbia University Medical Center, New York
- Northwell Health, New York
- a 1 ďalších
Prebieha náborObservačná štúdia
Vek 18 až 110 · Všetky pohlavia · Aktualizované 15. 4. 2026 · NCT05934149Safety and Efficacy of ONT01 in Lupus
- Hospital for Special Surgery, New York
Prebieha náborSkorá fáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 11. 2025 · NCT07107659Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
- The Rogosin Institute, New York
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 4. 2025 · NCT01802034Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.